BURNABY, BRITISH COLUMBIA--(Marketwire - Nov. 8, 2010) - Lifebank Corp. ("Lifebank" or the "Company") (TSX VENTURE:LBK) announces that a total of 100,000 incentive stock options have been granted to Jeff Charpentier, the Company's Chief Financial Officer pursuant to the Company's Stock Option Plan. The options are exercisable for a period of five (5) years at a price of $0.16 per share.
Started in 1996, Lifebank is a leading national company in the biomedical field. Based at the British Columbia Institute of Technology campus in Burnaby, Lifebank provides processing and cryogenic (ultra low temperature) storage of umbilical cord blood stem cells for families in Canada and world-wide. A full description of the advantages and benefits of storing the stem cells from an infant's umbilical cord can be found on the Company's website at www.lifebank.com.
On January 21, 2004, Lifebank received official accreditation from the international organization AABB and was the first accredited cord blood stem cell bank in Canada. In February 2010, celebrating another milestone in Cellular Therapy and Transplant Medicine, Lifebank has achieved the globally recognized FACT accreditation.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.